We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Roche NimbleGen and Affymetrix Expand Licensing Agreement

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "Roche NimbleGen and Affymetrix Expand Licensing Agreement"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

Roche NimbleGen Inc., a company of Roche Applied Science, and Affymetrix Inc. announced that they have expanded the terms of the license to a number of Affymetrix patents originally granted in October 2006.

The expanded license now provides certain diagnostic rights for array-based DNA copy number analysis and array-based re-sequencing in addition to covering the manufacture, use and sale of nucleic acid microarrays and related products and services in the research field. Financial details of the expanded license were not disclosed.